LEBANON, N.H., Oct. 14, 2025 /PRNewswire/ -- Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly ...
Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...
SAN FRANCISCO--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced that it has expanded its collaboration with ...
New Hampshire’s Bio X Cell, which has made a name for itself over the past quarter-century cranking out functional antibodies for in vivo research, is embarking on the next leg of its international ...
SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and ...
Xcell Biosciences Australia, an affiliate of Xcell Biosciences, and Royal Perth Hospital agreed to collaborate on developing an automated, clinical-scale manufacturing workflow for therapies based on ...
Xcell Biosciences expanded its collaboration with AmplifyBio, a CDMO, by installing a new AVATAR™ Foundry system as part of Xcellbio’s beta access program. The new instrument will enable AmplifyBio’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback